These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 20374188

  • 1. Omega 3 polyunsaturated fatty acids supplementation and blood pressure levels in hypertriglyceridemic patients with untreated normal-high blood pressure and with or without metabolic syndrome: a retrospective study.
    Cicero AF, Derosa G, Di Gregori V, Bove M, Gaddi AV, Borghi C.
    Clin Exp Hypertens; 2010 Jan; 32(2):137-44. PubMed ID: 20374188
    [Abstract] [Full Text] [Related]

  • 2. Does supplementation of diet with 'fish oil' reduce blood pressure? A meta-analysis of controlled clinical trials.
    Appel LJ, Miller ER, Seidler AJ, Whelton PK.
    Arch Intern Med; 1993 Jun 28; 153(12):1429-38. PubMed ID: 8141868
    [Abstract] [Full Text] [Related]

  • 3. Omega-3 polyunsaturated fatty acids and proxies of cardiovascular disease in hemodialysis: a prospective cohort study.
    Vernaglione L, Cristofano C, Chimienti S.
    J Nephrol; 2008 Jun 28; 21(1):99-105. PubMed ID: 18264942
    [Abstract] [Full Text] [Related]

  • 4. Omega-3 polyunsaturated fatty acid supplements and ambulatory blood pressure monitoring parameters in patients with mild essential hypertension.
    Russo C, Olivieri O, Girelli D, Azzini M, Stanzial AM, Guarini P, Friso S, De Franceschi L, Corrocher R.
    J Hypertens; 1995 Dec 28; 13(12 Pt 2):1823-6. PubMed ID: 8903660
    [Abstract] [Full Text] [Related]

  • 5. Metabolic syndrome and new category 'pre-hypertension' in a Japanese population.
    Kanauchi M, Kanauchi K, Hashimoto T, Saito Y.
    Curr Med Res Opin; 2004 Sep 28; 20(9):1365-70. PubMed ID: 15383184
    [Abstract] [Full Text] [Related]

  • 6. [Influence of some parameters on the blood pressure reduction under treatment: experience from the Hypertension Optimal Treatment Study].
    Mallion JM, Baguet JP, Siché JP, Benkritly A.
    Arch Mal Coeur Vaiss; 1998 Aug 28; 91(8):1049-53. PubMed ID: 9749163
    [Abstract] [Full Text] [Related]

  • 7. Dietary fat modifications and blood pressure in subjects with the metabolic syndrome in the LIPGENE dietary intervention study.
    Gulseth HL, Gjelstad IM, Tierney AC, Shaw DI, Helal O, Hees AM, Delgado-Lista J, Leszczynska-Golabek I, Karlström B, Lovegrove J, Defoort C, Blaak EE, Lopez-Miranda J, Dembinska-Kiec A, Risérus U, Roche HM, Birkeland KI, Drevon CA.
    Br J Nutr; 2010 Jul 28; 104(2):160-3. PubMed ID: 20202290
    [Abstract] [Full Text] [Related]

  • 8. Repeated fasting and refeeding with 20:5, n-3 eicosapentaenoic acid (EPA): a novel approach for rapid fatty acid exchange and its effect on blood pressure, plasma lipids and hemostasis.
    Yosefy C, Viskoper JR, Varon D, Ilan Z, Pilpel D, Lugassy G, Schneider R, Savyon N, Adan Y, Raz A.
    J Hum Hypertens; 1996 Sep 28; 10 Suppl 3():S135-9. PubMed ID: 8872845
    [Abstract] [Full Text] [Related]

  • 9. Reduction of blood pressure and plasma triglycerides by omega-3 fatty acids in treated hypertensives.
    Lungershausen YK, Abbey M, Nestel PJ, Howe PR.
    J Hypertens; 1994 Sep 28; 12(9):1041-5. PubMed ID: 7852747
    [Abstract] [Full Text] [Related]

  • 10. Relationship between the metabolic syndrome and the development of hypertension in the Hong Kong Cardiovascular Risk Factor Prevalence Study-2 (CRISPS2).
    Cheung BM, Wat NM, Man YB, Tam S, Cheng CH, Leung GM, Woo J, Janus ED, Lau CP, Lam TH, Lam KS.
    Am J Hypertens; 2008 Jan 28; 21(1):17-22. PubMed ID: 18091739
    [Abstract] [Full Text] [Related]

  • 11. Omega-3 fatty acids improve blood pressure control and preserve renal function in hypertensive heart transplant recipients.
    Holm T, Andreassen AK, Aukrust P, Andersen K, Geiran OR, Kjekshus J, Simonsen S, Gullestad L.
    Eur Heart J; 2001 Mar 28; 22(5):428-36. PubMed ID: 11207085
    [Abstract] [Full Text] [Related]

  • 12. The effect of n-3 fatty acids on C-reactive protein levels in patients with chronic renal failure.
    Madsen T, Schmidt EB, Christensen JH.
    J Ren Nutr; 2007 Jul 28; 17(4):258-63. PubMed ID: 17586424
    [Abstract] [Full Text] [Related]

  • 13. [Antihypertensive effect and safety evaluation of vegetable drink with peptides derived from sardine protein hydrolysates on mild hypertensive, high-normal and normal blood pressure subjects].
    Kawasaki T, Jun CJ, Fukushima Y, Kegai K, Seki E, Osajima K, Itoh K, Matsui T, Matsumoto K.
    Fukuoka Igaku Zasshi; 2002 Oct 28; 93(10):208-18. PubMed ID: 12471719
    [Abstract] [Full Text] [Related]

  • 14. [A Brazilian multicenter study to evaluate the clinical effectiveness and tolerance of isradipine SRO using ambulatory monitoring of arterial pressure in the treatment of mild and moderate arterial hypertension].
    Magliano MF, Amodeo C, Mion Júnior D, Francischetti E, Lima Júnior E, Nobre F, Chaves H, Ribeiro JM, Spritzer N, Jardim PC.
    Arq Bras Cardiol; 1993 Nov 28; 61(5):311-8. PubMed ID: 8147731
    [Abstract] [Full Text] [Related]

  • 15. The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study.
    Svensson M, Schmidt EB, Jørgensen KA, Christensen JH.
    Nephrol Dial Transplant; 2008 Sep 28; 23(9):2918-24. PubMed ID: 18436564
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D.
    Clin Ther; 2005 May 28; 27(5):578-87. PubMed ID: 15978306
    [Abstract] [Full Text] [Related]

  • 17. Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study.
    Egert S, Bosy-Westphal A, Seiberl J, Kürbitz C, Settler U, Plachta-Danielzik S, Wagner AE, Frank J, Schrezenmeir J, Rimbach G, Wolffram S, Müller MJ.
    Br J Nutr; 2009 Oct 28; 102(7):1065-74. PubMed ID: 19402938
    [Abstract] [Full Text] [Related]

  • 18. Sympathetic hypertensive syndrome: a possible surgically curable type of hypertension.
    Chou SH, Kao EL, Lin CC, Chuang HY, Huang MF.
    Hypertens Res; 2005 May 28; 28(5):409-14. PubMed ID: 16156504
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: a retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension.
    Germino FW.
    Clin Ther; 2009 Sep 28; 31(9):1946-56. PubMed ID: 19843484
    [Abstract] [Full Text] [Related]

  • 20. The Hypertension Optimal Treatment study and the importance of lowering blood pressure.
    Hansson L.
    J Hypertens Suppl; 1999 Feb 28; 17(1):S9-13. PubMed ID: 10340838
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.